Versigent (NYSE:VGNT) Receives Consensus Recommendation of "Buy" from Analysts

Versigent (NYSE:VGNT - Get Free Report) has received a consensus rating of "Buy" from the five ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $38.25.Several equities analysts have issued reports on the stock. Royal Bank Of Canada assumed coverage on shares of Versigent in a research note on Tuesday, March 31st. They issued a "sector perform" rating and a $28.00 price objective for the company. Wells Fargo & Company assumed coverage on shares of Versigent in a research note on Monday, April 6th. They issued an "overweight" rating and a $35.00 price objective for the company. Fox Advisors upgraded shares of Versigent to a "strong-buy" rating in a research note on Tuesday, April 7th. Wall Street Zen upgraded shares of Versigent to a "hold" rating in a research note on Saturday. Finally, UBS Group assumed coverage on shares of Versigent in a research note on Tuesday. They issued a "buy" rating and a $43.00 price objective for the company.Check Out Our Latest Analysis on VersigentVersigent Price PerformanceShares of VGNT stock opened at $34.69 on Friday. Versigent has a 12 month low of $26.34 and a 12 month high of $35.08. Featured StoriesFive stocks we like better than VersigentThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Versigent Right Now?Before you consider Versigent, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.While Versigent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here